Longevity research remains fixated on the terminal event, treating death as the only data point that counts. In reality, systems biology shows us that death is just a lagging indicator of a crash that started decades earlier. Aging isn’t some slow, linear slide; it's a phase transition where a system moves from a compensated state to an uncompensated one.

If you examine bile acid pools or the circadian rhythms of the microbiome, you don’t see a gradual decline. You see a system fighting to maintain homeostatic buffering until it finally hits a wall. By the time a chronic disease manifests—whether it’s insulin resistance or a localized inflammatory flare—the system’s already lost its dampening capacity. We’re currently funding the study of the wreckage instead of investigating why the brakes failed in the first place.

Using all-cause mortality as a primary endpoint is intellectually lazy. There’s a massive biological difference between someone who dies at 95 after two weeks of acute failure and someone who dies at 95 after twenty years of managed decline. In the first case, the architectural integrity of their metabolic feedback loops held until the very end. The second person is more like a "living ghost"—a collection of subsystems tethered together by pharmacology that lost their emergent coherence years ago.

To actually solve aging, we have to fund the Dynamic Stress Test. We shouldn't be looking at static biomarkers of damage. Instead, we need to measure how quickly a system returns to baseline after a bile acid provocation or a circadian shift. Longevity is the duration of the compensated state, not the distance to the grave.

I’m looking for collaborators to help map these "first-failure" thresholds in the gut-liver axis. We need a rigorous way to define the Morbidity Plateau before the cliff. If we can’t measure the exact moment a system loses its ability to self-correct, we aren't practicing preventative medicine—we’re just performing forensic accounting on a dying species.